MIRA
INFORM REPORT
|
Report Date : |
16.09.2014 |
IDENTIFICATION DETAILS
|
Name : |
DAKO DENMARK AS |
|
|
|
|
Registered Office : |
Produktionsvej 42, Glostrup 2600 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
2013 |
|
|
|
|
Date of Incorporation : |
15.06.1967 |
|
|
|
|
Com. Reg. No.: |
33211317 |
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
Line of Business : |
Manufacture of Other Chemical Products. |
|
|
|
|
No of Employees : |
572 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 01, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
Denmark |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderate Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderate High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
DENMARK - ECONOMIC OVERVIEW
This thoroughly modern market
economy features a high-tech agricultural sector, state-of-the-art industry
with world-leading firms in pharmaceuticals, maritime shipping and renewable
energy, and a high dependence on foreign trade. Denmark is a member of the
European Union (EU); Danish legislation and regulations conform to EU standards
on almost all issues. Danes enjoy a high standard of living and the Danish
economy is characterized by extensive government welfare measures and an
equitable distribution of income. Denmark is a net exporter of food and energy
and enjoys a comfortable balance of payments surplus, but depends on imports of
raw materials for the manufacturing sector. Within the EU, Denmark is among the
strongest supporters of trade liberalization. After a long consumption-driven
upswing, Denmark's economy began slowing in 2007 with the end of a housing
boom. Housing prices dropped markedly in 2008-09 and, following a short respite
in 2010, have since continued to decline. Household indebtedness is still
relatively high at more than 275% of gross disposable income in the first half
of 2013. The global financial crisis has exacerbated this cyclical slowdown
through increased borrowing costs and lower export demand, consumer confidence,
and investment. Denmark made a modest recovery in 2010, in part because of
increased government spending; however, the country experienced a technical
recession in late 2010-early 2011. Historically low levels of unemployment rose
sharply with the recession and have remained at about 6% in 2010-13, based on
the national measure, about two-thirds average EU unemployment. An impending
decline in the ratio of workers to retirees will be a major long-term issue.
Denmark maintained a healthy budget surplus for many years up to 2008, but the
budget balance swung into deficit in 2009, where it remains. In spite of the
deficits, the new coalition government delivered a modest stimulus to the
economy in 2012. Nonetheless, Denmark's fiscal position remains among the
strongest in the EU with public debt at about 46% of GDP in 2013. Despite
previously meeting the criteria to join the European Economic and Monetary
Union (EMU), so far Denmark has decided not to join, although the Danish krone
remains pegged to the euro.
|
Source
: CIA |
REGISTERED NAME & COMPANY
SUMMARY
|
Business Name |
DAKO DENMARK AS |
|
Country |
DENMARK |
|
Company Registration Number/CVR |
33211317 |
|
Main Code |
205900 |
|
Main Activity |
Manufacture of other chemical products n.e.c. |
|
Company Status |
Active |
|
Latest Revenue |
|
|
Latest Shareholder Equity |
1.151.275 |
|
Provider Rating Description |
Businesses at this level are regarded as having excellent
creditworthiness. Small businesses only have a limited possibility of achieving
this level. Businesses at this level are in a class by themselves and will
have results or financial foundations which are among the best in the
country. The credit risk is regarded as minimal. |
Company Information
|
Basic Information |
|
|
Business Name |
Dako Denmark A/S |
|
Registered Company Name |
Dako Denmark A/S |
|
Company Registration Number |
33211317 |
|
Country |
DENMARK |
|
Date of Company Registration |
1967-06-15 |
|
Legal Form |
Limited company |
|
Company Status |
Active |
|
Currency of this Report |
DKK |
|
Principal Activity Code |
205900 |
|
Principal Activity Description |
Manufacture of other chemical products n.e.c. |
|
Contact Address |
Produktionsvej 42, Glostrup 2600 |
|
Contact Telephone Number |
44859500 |
DIRECTORS/MANAGEMENT
Directors/Managers
|
Current Directors |
||
|
Name |
Position |
Start Date |
|
Britt Meelby
Jensen |
Managing director |
|
|
Hubertus Rolf Kühner |
Chairman |
|
|
Frédéric Andre Gabriel Laget |
Member of the board |
|
|
Richard Norman Larsen |
Member of the board |
|
|
Stig Henrik
Hansen |
Elected by employees |
|
|
Kenneth Heesche Petersen |
Elected by employees |
|
|
Henrik
Anker-Jensen |
Production |
|
NEGATIVE INFORMATION
No negative information found.
SHARE & SHARE CAPITAL
INFORMATION
Share Capital
Structure
|
Currency |
DKK |
|
Nominal Share Capital |
61.681.680 |
PAYMENT INFORMATION
|
Global Trading Information |
|
|
Export |
Worldwide |
|
Import |
|
GROUP STRUCTURE & AFFILIATED
COMPANIES
Group Structure
|
Ultimate Holding
Parent |
|
|
Name |
Country |
|
Dako A/S |
|
|
Subsidiaries |
|
|
Name |
Country |
|
Dako Canada Inc. |
CANADA |
|
Dako Deutschland GmbH |
GERMANY |
|
Dako Japan Inc. |
JAPAN |
|
Dako France S.A.S |
FRANCE |
|
Dako Italia S.p.A. |
ITALY |
|
Dako Australia Pty. Ltd. |
AUSTRALIA |
|
Dako Schweiz AG |
SWITZERLAND |
|
Dako Belgium N.V |
BELGIUM |
|
Dako Netherlands B.V |
NETHERLANDS |
|
Dako Österreich
GmbH |
AUSTRIA |
|
Dako Sweden AB |
SWEDEN |
|
Dako Finland Oy |
FINLAND |
|
Dako InstrumeC AS |
NORWAY |
|
Dako do Brazil LTDA |
BRAZIL |
|
Dako Diagnostics (Shanghai) CO. Ltd. |
CHINA |
|
Dako Diagnostics Ireland Ltd. |
IRELAND |
|
Dako North America Inc. |
UNITED STATES |
|
Dako UK Ltd |
UNITED KINGDOM |
|
Dako Diagnósticos S.A. |
SPAIN |
|
Dako Polska Sp.
z o.o. |
POLAND |
|
Fako Korea Co., Ltd. |
REPUBLIC OF KOREA |
FINANCIAL INFORMATION
ACCOUNTS
|
PROFIT AND LOSS |
|||
|
FINANCIAL DATE |
2013 |
2012 |
2011 |
|
Number of Weeks |
52 |
43 |
52 |
|
Currency |
DKK |
DKK |
DKK |
|
Revenue |
1.282.334.000 |
1.014.786.000 |
1.242.655.000 |
|
Operating Profit |
97.526.000 |
153.530.000 |
345.398.000 |
|
Retained Profit |
-10.083.000 |
177.488.000 |
245.018.000 |
|
BALANCE SHEET |
|||
|
FINANCIAL DATE |
2013 |
2012 |
2011 |
|
Number of Weeks |
52 |
43 |
52 |
|
Currency |
DKK |
DKK |
DKK |
|
Total Assets |
1.972.267.000 |
1.977.318.000 |
1.803.896.000 |
|
Other Reserves |
1.151.275.000 |
1.161.857.000 |
979.175.000 |
|
ADDITIONAL ACCOUNTS
INFORMATION |
|
|
Date Format |
MM-DD |
|
Accounts Start Date |
11-01 |
|
Accounts End Date |
10-31 |
FOREIGN EXCHANGE RATES
N/A
ADDITIONAL INFORMATION
|
Activities |
|
|
Activity Code |
Activity Description |
|
205900 |
Manufacture of other chemical products n.e.c. |
|
Previous Names |
|
|
Previous Name |
Date Changed from Previous Name |
|
Dako A/S |
|
|
Dakocytomation Denmark A/S |
|
CONTACT INFORMATION
|
Main Address |
||
|
Address |
Country |
Telephone |
|
Produktionsvej 42, Glostrup 2600 |
DENMARK |
44859500 |
|
Email Addresses |
|
kontakt@dako.dk |
|
Web Pages |
|
www.dako.com |
OTHER INFORMATION
|
Employee Information |
|
|
Year Reported |
Number of Employees |
|
2013 |
572 |
|
2012 |
519 |
|
2011 |
495 |
|
Real Estate |
|
|
Real Estate |
No |
|
Other Trading Names |
|
|
Type |
Name |
|
Business name |
Dako Immunoglobulins A/S |
|
Business name |
Dakocytomation Denmark A/S |
|
Business name |
Dakopatts A/S |
|
Global Trading Information |
|
|
Export |
Worldwide |
|
Import |
|
|
Other Information |
|
|
Type |
Text |
|
Capital conditions |
fully paid up |
|
Authorisation to sign |
the chairman of the board together with a member of the board or a manager together with a member of the board or the entire board of directors |
|
Additional Accounts Notes |
|
|
Notes Date |
Notes Detail |
|
12/1-01-01T00:00:00 |
In the financial statement of 12/13 attention is drawn to leasing commitments. |
|
Other Trading Names |
|
|
Type |
Name |
|
Business name |
Dako Immunoglobulins A/S |
|
Business name |
Dakocytomation Denmark A/S |
|
Business name |
Dakopatts A/S |
|
Other Information |
|
|
Type |
Text |
|
Capital conditions |
fully paid up |
|
Authorisation to sign |
the chairman of the board together with a member of the board or a manager together with a member of the board or the entire board of directors |
NOTES & COMMENTS
N/A
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.99 |
|
|
1 |
Rs.99.10 |
|
Euro |
1 |
Rs.79.03 |
INFORMATION DETAILS
|
Analysis Done by
: |
RAS |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation
is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.